Holen Sie sich die Stockscreener-App
4.1039
2.10%
0.0339
Briacell Therapeutics Corp Aktie (BCTX) Neueste Nachrichten
BriaCell receives FDA clearance for breast cancer therapy trial - Investing.com
FDA clears BriaCell's personalized breast cancer study to start - Stock Titan
BriaCell Receives FDA Clearance to Initiate Bria-BRES+™ Clinical Study in Breast Cancer - GlobeNewswire
MSN Money - MSN
BriaCell Announces Six Clinical Data Presentations at ASCO 2026 - The Manila Times
Six metastatic breast cancer studies put BriaCell on ASCO's 2026 agenda - Stock Titan
BriaCell to implement 1-for-10 reverse stock split to maintain Nasdaq listing - MSN
BrianCell Therapeutics drops 10%, prices $30M offering at $5.59 per unit - MSN
BriaCell (BCTXL) Q4 Outlook Earnings ReportHigh Volatility - Cổng thông tin điện tử tỉnh Lào Cai
BCTX (BriaCell Therapeutics Corp.) posts narrower than expected Q1 2026 loss, shares rise 1.76% today.Hot Community Stocks - Cổng thông tin điện tử Tỉnh Sơn La
BCTXZ (BriaCell) outlines late-stage oncology pipeline progress as key focus in latest quarterly earnings release.Crowd Consensus Signals - Cổng thông tin điện tử tỉnh Tây Ninh
BriaCell Shares Slide 22% After Announcing Dilutive Public Offering - MSN
BriaCell Therapeutics : Investor Presentation (2026Apr21 Investor Presentation) - marketscreener.com
Stocks in play: BriaCell Therapeutics Corp. - Barchart.com
BriaCell Therapeutics Corp. - Baystreet.ca
BriaCell (BCTX) Showcases Promising Data at AACR Annual Meeting - GuruFocus
BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ in Preclinical Cancer Models - The Manila Times
BriaCell presents phase 3 breast cancer quality of life data at AACR - Investing.com India
BriaCell Therapeutics : Investor Presentation (2026Apr20 Investor Presentation) - marketscreener.com
BriaCell (BCTX) Showcases Positive Clinical Data at AACR Annual Meeting - GuruFocus
BriaCell presents phase 3 breast cancer quality of life data at AACR By Investing.com - Investing.com South Africa
What should I do with BriaCell (BCTX) stock today (Pressure Mounts) 2026-04-20Retail Trader Ideas - Cổng thông tin điện tử tỉnh Lào Cai
BriaCell Presents Positive Phase 3 Quality of Life and Phase 2 Biomarker Data at the 2026 AACR Meeting - Investing News Network
Late-stage breast cancer patients preserved quality of life in trial - Stock Titan
BriaCell: Advancing Toward Approval with Late-Stage Breast Cancer Immunotherapy - The Globe and Mail
Certain Performance Share Units of BriaCell Therapeutics Corp. are subject to a Lock-Up Agreement Ending on 15-APR-2026. - marketscreener.com
Certain Options of BriaCell Therapeutics Corp. are subject to a Lock-Up Agreement Ending on 15-APR-2026. - marketscreener.com
Certain Warrants of BriaCell Therapeutics Corp. are subject to a Lock-Up Agreement Ending on 15-APR-2026. - marketscreener.com
BriaCell Therapeutics Corp. (BCTXW) - Minichart
BriaCell Stock Dips After-Hours On Pricing $13.8M Public Offering, But Retail's Busy Cheering Clinical Milestone - MSN
What is happening with BriaCell (BCTX) Stock right now | BCTX Q4 Earnings: Beats Estimates by $2.31Financial Update - UBND thành phố Hải Phòng
Growth Report: Does BriaCell Therapeutics Corp align with a passive investing strategy2026 Action & Growth Oriented Trade Recommendations - baoquankhu1.vn
Sectors Review: Is BriaCell Therapeutics Corp Equity Warrant stock a hidden gem2026 Key Lessons & Risk Managed Investment Signals - baoquankhu1.vn
Briacell Therap (NASDAQ:BCTX) Cut to “Strong Sell” at Wall Street Zen - Defense World
Is BriaCell (BCTXL) Stock Leading the Market | Price at $1.06, Up 2.40%Open Stock Signal Network - Cổng thông tin điện tử Tỉnh Sơn La
0.78%
3.99%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):